Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_assertion description "[Our findings demonstrated that HCV patients classified as 'good sleeper' displayed an enhanced frequency of circulating CD8(+) T cells, lower frequency of activated (CD69(+)) neutrophils and eosinophils but enhanced frequency of activated lymphocytes besides lower seric levels of IL-4/IL-8/IL-10 but higher levels of IL-12, besides lower HCV virus load and lower anti-HCV IgG levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_assertion evidence source_evidence_literature NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_assertion SIO_000772 21231952 NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_assertion wasDerivedFrom befree-20140225 NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_assertion wasGeneratedBy ECO_0000203 NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP320752.RACiVJpsKkCWFD_XBHU4-lMeOYPWtjQ9blGHRGftX386M130_provenance.